3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
3
Colonic Neoplasms
3
Stomach Neoplasms
2
Motor Activity
2
Liver Neoplasms
2
Colorectal Neoplasms
2
Sarcopenia
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatitis, Chronic
1
Ovarian Neoplasms
1
Malnutrition
1
Lung Neoplasms
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Disease
1
Cholangiocarcinoma
1
Cachexia
1
Breast Neoplasms
1
Bile Duct Neoplasms
1
Appendiceal Neoplasms
1
Interventions
pembrolizumab
50
Cyclophosphamide
25
Carboplatin
25
Gemcitabine
20
Cisplatin
19
fludarabine
18
Nivolumab
17
Paclitaxel
16
Bevacizumab
15
Specimen Handling
14
Fluorouracil
11
Magnetic Resonance Spectroscopy
10
aldesleukin
9
Oxaliplatin
9
Irinotecan
9
Docetaxel
9
Biopsy
9
olaparib
8
Trastuzumab
8
durvalumab
7
atezolizumab
7
Hyperthermic Intraperitoneal Chemotherapy
7
Albumin-Bound Paclitaxel
7
Taxes
6
Leucovorin
6
Ipilimumab
6
Interleukin-2
6
Cetuximab
6
Capecitabine
6
130-nm albumin-bound paclitaxel
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Nutritional Status
×
Gastrointestinal
×
Clear all
NCT05305820
2024-03-21
PANO
Dublin City University
Phase NA
Unknown
36 enrolled